Chart - you can draw at the chart
Starting Amount
$
After
years
Dividend yield
%
Dividends reinvested
$
Bio-Techne Corporation
Type
Public
Traded as
  • NASDAQ: TECH
  • S&P 400 Component
Industry
  • biotechnology
  • clinical diagnostic
Founded 1976
Founder Dr. Roger C. Lucas
Headquarters Minneapolis, Minnesota, United States
Key people
Chuck Kummeth (President, CEO)
Products 24,000 products, 14,000 of which are antibodies (2014)
Revenue
  • Increase $452M (2015)
  • Increase $358M (2014)
Number of employees
>1,000 (2014)
Website Bio-Techne
Footnotes / references

Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's brands include flagship R&D Systems (Research and Diagnostic Systems Inc.), Boston Biochem, Tocris Bioscience, BiosPacific and Bionostics. The company's products are used in both clinical and research contexts. The company was co-founded as a "hematology controls developer" by Dr. Roger C. Lucas, who presently serves as its Chief Scientific Advisor.

Bio-Techne is listed on the NASDAQ under the ticker symbol TECH. Writing for Forbes from an investor's perspective, John Reese praised the management team saying it "...appears to be doing a solid job...", a sentiment echoed by Philip van Doorn, writing for Dow Jones MarketWatch. Interviewing investor Edward B. White for the New York Times, Carole Gould noted that White thought the chief executive, Thomas Oland, was a "deeply committed scientist."

Beginning in 2013, the company's chief executive officer was Chuck Kummeth, who had previously been employed by Thermo Fisher Scientific.

Investment goal date:
Dividends reinvested
Bio-Techne Corporation TECH report Q1 2018
Period
Date
Adjusted Actuals EPS
GAAP EPS
Q3 2018
2018-05-03
--
--
Q2 2018
2018-02-05
--
--
Q1 2018
2017-10-31
0.9000
0.4200
Q4 2017
2017-08-08
1.0900
0.7400
Q3 2017
2017-05-02
0.9700
0.5900
Q2 2017
2017-02-07
0.8100
0.2000
Q1 2017
2016-10-31
0.8400
0.5000
Q4 2016
2016-08-17
0.9200
0.6900
Q3 2016
2016-05-03
1.0100
0.8100
Q2 2016
2016-02-02
0.8800
0.6900
There is presents forecasts or rating agencies and recommendation for investors about this ticker
Funds
Fund Name
Ticker shares
BAMCO INC /NY/
1513617
BlackRock Fund Advisors
1966951
BlackRock Inc.
3500436
BlackRock Institutional Trust Company, N.A.
1135350
BROWN CAPITAL MANAGEMENT LLC
2147690
Jackson Square Partners, LLC
1089405
JANUS CAPITAL MANAGEMENT LLC
941663
MACKENZIE FINANCIAL CORP
632301
MAIRS & POWER INC
1389850
Neuberger Berman Group LLC
1900495
RIVERBRIDGE PARTNERS LLC
604797
ROYCE & ASSOCIATES LLC
804859
Select Equity Group, L.P.
2432176
STATE STREET CORP
989661
Vanguard Group, Inc
3005690
Major Shareholders
Name Relationship
Total Shares
Holding stocks
TECHNE CORP /MN/
16.8500% (6235056)
TECH /
OLAND THOMAS E
3.1800% (1177420)
TECH /
LUCAS ROGER C
0.0100% (1870)
CCXI / TECH /
WIENS HAROLD J
0.0100% (4212)
TECH /
STEER RANDOLPH C
0.0100% (3712)
CAPS / TECH / VTL /
HIGGINS JOHN L
0.0100% (3012)
BCRX / LGND / TECH /
VERONNEAU MARCEL
0.0900% (34604)
TECH /
OCONNELL HOWARD V
0.1900% (70000)
TECH /
BAUMGARTNER ROBERT V
0.0200% (7712)
TECH /
EANSOR N DAVID
0.0100% (3402)
TECH /
Dinarello Charles A
0.0200% (8212)
TECH /
Nusse Roeland
0.0100% (4712)
TECH /
Kummeth Charles R.
0.2300% (84472)
SPA / TECH /
% ()